Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Study of ASTX029 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
Taiho Oncology conducted a Phase 1/2 study of ASTX029 in adults with advanced solid tumors. The trial is completed and results have been pos…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study evaluating safety, pharmacokinetics, and anti-tumor activity of GDC-1971 in combination with atezolizumab in locally advanced …
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers [Phase 1]
Phase 1 study results for TTX-030 as a single agent and in combination with immunotherapy or chemotherapy in patients with advanced solid tu…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Biological Age Predicts 90-Day Mortality in Advanced Cancer
This completed trial suggests that biological age can predict 90-day mortality in patients with advanced cancer.
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7 [Phase 1]
A Phase 1 study of NPX267 in subjects with solid tumors expressing HHLA2/B7-H7 is currently suspended. Sponsor: NextPoint Therapeutics, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: The Safety and Efficacy of Multiple-dose of WJ01024 in Subject With Advanced Cancer [Phase 1]
Phase 1 clinical trial evaluating multiple doses of WJ01024 in patients with advanced cancer was terminated; the study assessed safety and e…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: A Study of MK-0482 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-0482-001) [Phase 1]
Phase 1 study of MK-0482 as monotherapy and in combination with pembrolizumab in participants with advanced solid tumors has completed, repo…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 dose-escalation and expansion study of XL495 in locally advanced or metastatic solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b [Phase 1]
A first-in-human Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of DS-6051b in solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Weekly Intravenous Administrations of BI 836845 in Japanese Patients With Advanced Solid Tumours [Phase 1]
This Phase 1 trial assessed weekly intravenous administration of BI 836845 in Japanese patients with advanced solid tumors. The study is com…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of a Recombinant Humanized mAb Specific to B-and T-Lymphocyte Attenuator (BTLA) for Injection in Subjects With Advanced Malignancies [Phase 1]
Phase 1 study evaluating safety, tolerability and pharmacokinetics of a recombinant humanized anti-BTLA monoclonal antibody in patients with…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: APG-2449 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial of APG-2449 in patients with advanced solid tumors is currently recruiting, including non-small cell lung cancer, esophageal…
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: The Clinical Study of SHR-7631 for Injection in Patients With Advanced Solid Tumors [Phase 1]
This document reports the completion of a Phase 1 clinical trial evaluating SHR-7631 for injection in patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: National Project on Vaccines, COVID-19 and Frail Patients
The trial update reports the completion of a national project evaluating COVID-19 vaccines in frail patients, including those with solid tum…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Real-life Performance Evaluation of the LiFlow X-ray Platform
This trial update outlines a real-world performance evaluation of the LiFlow X-ray platform in solid tumors, with recruitment not yet starte…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001) [Phase 1]
Phase 1 trial update of favezelimab (MK-4280) as monotherapy or in combination with pembrolizumab (MK-3475), with or without chemotherapy or…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: RTA 402 in Patients With Advanced Solid Tumors or Lymphoid Malignancies [Phase 1]
Phase 1 trial update of RTA 402 (bardoxolone methyl) in patients with advanced solid tumors or lymphoid malignancies; the study has complete…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating the safety, tolerability, pharmacokinetics, and antitumor activity of ADCT-901 in participants with sele…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Measuring the Impact of MANNA s Medically Tailored Meal Program in Patients With a Non-terminal Cancer Diagnosis
This clinical trial update notes the completed study assessing the impact of MANNA's Medically Tailored Meal Program in patients with non-te…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors [Phase 1]
Phase 1 study of Mipasetamab Uzoptirine (ADCT-601) in participants with solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer [Phase 1, Phase 2]
This clinical trial update reports that CFI-402257, a potent and selective TTK inhibitor, is being studied in Phase 1/Phase 2 trials for adv…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors [Phase 1]
Relay Therapeutics' first-in-human Phase 1 study of RLY-5836 in advanced breast cancer and other solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Food Safety Educational Training Program to Improve Food Safety Knowledge and Behaviors in Cancer Patients Receiving Treatment [NA]
Completed clinical trial evaluating a food safety educational training program designed to improve food safety knowledge and behaviors in ca…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating APR-246 in combination with pembrolizumab in solid tumors has completed enrollment with results posted…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: Study to Determine the Maximum Tolerated Dose (MTD) of PARPi 2X-121 Monotherapy and the MTD of Dovitinib in Combination With 2X-121 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study to determine the maximum tolerated dose of PARPi 2X-121 as a monotherapy and in combination with dovitinib in patients with ad…